Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis

The aim of this study is to evaluate the impact of diabetes, hypertension, cardiovascular disease and the use of angiotensin converting enzyme inhibitors/angiotensin II receptor blockers (ACEI/ARB) with severity (invasive mechanical ventilation or intensive care unit admission or O2 saturation 

Saved in:
Bibliographic Details
Published in:Diabetology and metabolic syndrome 2020-08, Vol.12 (1), p.75-12, Article 75
Main Authors: de Almeida-Pititto, Bianca, Dualib, Patrícia M, Zajdenverg, Lenita, Dantas, Joana Rodrigues, de Souza, Filipe Dias, Rodacki, Melanie, Bertoluci, Marcello Casaccia
Format: Article
Language:English
Subjects:
Analysis
Angiotensin
Angiotensin converting enzyme
Angiotensin II
Angiotensins
Cardiovascular disease
Cardiovascular diseases
Coronaviruses
COVID-19
Diabetes
Diabetes mellitus
Diabetics
Hypertension
Mechanical ventilation
Meta-analysis
Mortality
Patient outcomes
Peptidyl-dipeptidase A
Risk factors
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Severity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of this study is to evaluate the impact of diabetes, hypertension, cardiovascular disease and the use of angiotensin converting enzyme inhibitors/angiotensin II receptor blockers (ACEI/ARB) with severity (invasive mechanical ventilation or intensive care unit admission or O2 saturation 
ISSN:1758-5996
1758-5996
DOI:10.1186/s13098-020-00586-4